🔥 CYBER MONDAY SALE ENDS TONIGHT: Save 30% or more on all Examine products Save now »

Cannabidiol (CBD) As An Adjunctive Therapy In Schizophrenia: A Multicenter Randomized Controlled Trial

Effect Decrease
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 88
Sex n/a

Full details on all 2 studies are available to Examine members — On Sale for Black Friday! .

Already a Member? Log in now to access.